Image Credit: http://www.yicaiglobal.com
On January 20th, Shenzhen Mindray Biomedical Electronics published management estimates for it’s 2019 annual results. This financial data is not audited although the board of directors have signed off the disclosure as being true, accurate and complete. This early data indicates that Mindray delivered another year of strong sales revenue growth, although it was slightly less explosive than prior years. Overall sales revenue for FY 2019 was reported as ¥15.8 billion yuan, compared with ¥13.8 billion yuan in FY 2018, an increase of approximately +15% year-on-year. This implies a 4-year revenue CAGR of +18.5%.
2018 Revenue segmentation by Product and Major Geographic Region